首页> 外文期刊>Archives of medical research >Immunohistochemical analysis of prostate apoptosis response-4 (Par-4) in Mexican women with breast cancer: a preliminary study.
【24h】

Immunohistochemical analysis of prostate apoptosis response-4 (Par-4) in Mexican women with breast cancer: a preliminary study.

机译:墨西哥乳腺癌女性前列腺细胞凋亡应答4(Par-4)的免疫组织化学分析:一项初步研究。

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND AND AIMS: We undertook this study to compare the expression level of prostate apoptosis response-4 (Par-4) among patient outcome in two groups of women with breast cancer (short and long survival) and two groups without breast cancer (benign lesion and control). METHODS: We included breast specimens with nonhistological abnormalities (eight samples) as a control group. Semiquantitative and quantitative analysis of immunohistochemical staining by image analysis software were used to study the intensity of Par-4 expression. Both methods produced similar results (p>0.05). RESULTS: No significant expression of Par-4 was observed in normal breast tissue. Benign lesions and breast cancer tissue showed strong nuclear expression of Par-4, predominantly on epithelial cells and specifically in ductal cells. Par-4 expression was lower in myoepithelial cells and there was no appreciable stromal staining. Significantly less Par-4 reactivity was detected in tissue from patients with a short survival compared with patients with benign lesions and those with a long survival. CONCLUSIONS: Our findings suggest that a lower expression level of Par-4 is related to an unfavorable prognosis. A larger prospective study of samples of all patient groups with a longer follow-up is needed to validate this finding.
机译:背景与目的:我们进行了这项研究,以比较两组患有乳腺癌的妇女(短期和长期生存)和两组未患有乳腺癌的妇女(良性病变)的患者预后中前列腺细胞凋亡应答4(Par-4)的表达水平。和控制)。方法:我们将非组织学异常的乳腺标本(8个样本)作为对照组。使用图像分析软件对免疫组织化学染色进行半定量和定量分析,以研究Par-4表达的强度。两种方法产生的结果相似(p> 0.05)。结果:正常乳腺组织中未观察到Par-4的显着表达。良性病变和乳腺癌组织显示Par-4的强核表达,主要在上皮细胞上,特别是在导管细胞上。 Par-4在肌上皮细胞中的表达较低,并且没有明显的基质染色。与具有良性病变和具有长生存期的患者相比,具有短生存期的患者组织中检测到的Par-4反应性明显较低。结论:我们的发现表明,Par-4的较低表达水平与不良预后有关。需要对更大范围的随访对所有患者组的样本进行前瞻性研究,以验证这一发现。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号